文献速递血液净化与透析

以导管起始血液透析患者血管通路置入趋势

Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter.
PubMed 文献 · Clin J Am Soc Nephrol · 2026-04-27

美国回顾性队列研究纳入2016至2022年以中心静脉导管起始血液透析的522,598例患者,发现导管起始比例从62%升至74%,而6个月内动静脉内瘘或移植物置入比例从34%降至26%,校正后2022年置入风险较2016年低31%。

要点

  • 以导管起始血透患者比例从2016年62%升至2022年74%。
  • 起始后6个月内内瘘/移植物置入比例从34%降至26%。
  • 校正竞争风险后2022年置入风险较2016年下降31%。

核心结论

  • 以导管起始血液透析的患者中,6个月内动静脉内瘘或移植物置入率显著下降,与指南推荐相悖。

研究设计与样本

  • 回顾性队列研究,使用美国肾脏数据系统,纳入2016至2022年以中心静脉导管起始血液透析的522,598例患者。

主要发现

  • 以导管起始血透比例从2016年62%升至2022年74%(P<0.001)。
  • 起始后6个月内动静脉内瘘或移植物置入比例从34%降至26%(P<0.001)。
  • 校正Fine-Gray竞争风险后,2019年亚分布风险比0.89(95%CI 0.87-0.90),2020年0.77(0.76-0.78),2021年0.75(0.74-0.76),2022年0.69(0.68-0.70),以2016年为参照。
  • 标准化6个月累积置入率从2016年15%降至2022年11%(P<0.001)。

临床怎么用

  • 肾内科医生应关注以导管起始血透患者后续永久性血管通路置入率下降的趋势,并积极评估适时机置入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Between 2016 and 2022 the proportion of US patients starting hemodialysis with a catheter increased from 62% to 74%. Concurrently, placement of a fistula or graft in the first 6 months of dialysis decreased from 34% to 26%. After adjustment for baseline characteristics and patient mortality, fistula or graft placement was 31% lower in 2022 than in 2016. BACKGROUND: Vascular access practice guidelines recommend placement of a permanent vascular access-arteriovenous fistula (AVF) or graft (arteriovenous graft [AVG])-to avoid complications associated with central venous catheter (CVC). Despite these guidelines, there has been a recent decrease in predialysis AVF placement and an increase in patients starting hemodialysis with a CVC only. We evaluated whether there has been an increase in the placement of an AVF or AVG in the first 6 months after dialysis initiation to offset the increase in patients starting dialysis with a CVC. METHODS: This was a retrospective cohort study using the United States Renal Data System. We identified 522,598 patients initiating hemodialysis with a CVC between 2016 and 2022. The exposure was the calendar year of hemodialysis initiation, and the main outcome was the proportion of patients with placement of an AVF or AVG within 6 months of hemodialysis initiation. RESULTS: The proportion of patients initiating hemodialysis with a CVC only increased from 62% in 2016 to 74% in 2022 ( P < 0.001), while the proportion receiving an AVF or AVG within 6 months of dialysis initiation declined from 34% to 26% ( P < 0.001). In adjusted Fine-Gray competing risk analysis, compared with 2016 as the reference year, hazard ratios for AVF/AVG placement declined markedly beginning in 2019 (subdistribution hazard ratio, 0.89; 95% confidence interval, 0.87 to 0.90 in 2019; 0.77, 0.76 to 0.78 in 2020; 0.75, 0.74 to 0.76 in 2021; and 0.69, 0.68 to 0.70 in 2022). The standardized 6-month cumulative incidence of AVF/AVG placement decreased from 15% in 2016 to 11% in 2022 ( P < 0.001). CONCLUSIONS: Contrary to national vascular access guidelines, there has been a nearly one-third secular decrease in placement of an AVF or AVG among patients initiating hemodialysis with a CVC, compounding the lower rates of access placement prior to dialysis initiation.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Allon M, Zhang Y, Thamer M, et al. Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter. Clin J Am Soc Nephrol. 2026. PMID: 42043866. doi:10.2215/CJN.0000001076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。